State of the Art Lectures

Date: Tuesday 25 September 2018
Time: 15:00 – 18:20

Time Session
Chairs: Mark Jenkins (Australia), Pål Møller (Norway), Julian Sampson (UK)
15:00 – 15:18 Systematic testing: a pathologists viewpoint – Philip Quirke (UK)
15:18 – 15:36 Does fast cheap targeted DNA testing have a future? – John Burn (UK)
15:36 – 15:54 The potential of liquid biopsies in hereditary disease – Jesus Garcia Foncilla (Spain)
15:54 – 16:12 PMS2-associated Lynch syndrome: the odd one out – Sanne ten Broeke (The Netherlands)
16:15 – 16:45 Coffee break
Chairs: Finlay Macrae (Australia), Gabriela Möslein (Germany)
16:45 – 17:03 MUTYH mutations, polyposis and cancers: what we know so far – Aung Ko Win (Australia)
17:03 – 17:21 Update on serrated polyposis – Dan Buchanan (Australia)
17:21 – 17:39 CMMRD and young LS – Chrystelle Colas (France)
17:39 – 17:57 Primary and secondary prevention in Lynch syndrome – clinical lessons from molecular pathology – Aysel Ahadova (Germany)
17:57 – 18:15 Genomics and surgery – Dion Morton (UK)
18:15 – 18:20 Invitation to InSight 2019 – Finlay Macrae (Australia)
Top